Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers

Source: CNBC Top Stories | Published: October 16, 2025, 4:08 pm | Read Original

Bearish -71.4

Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers

The program will sell Xofluza through three pharmacies with a $50 cash pay option, which is 70% lower than the pill's current list price before insurance.

Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.

More Like This

Glideslope AI

Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers

The program will sell Xofluza through three pharmacies with a $50 cash pay option, which is 70% lower than the pill's current list price before insurance.

CNBC Top Stories • Oct 16, 2025 • Found on Glideslope.ai

Post hash: mmjdbbh • glideslope.ai/post/mmjdbbh

Sentiment

Bearish • Score: -71.4

-100 (Bearish) +100 (Bullish)

Fraywire Market Portal, Breaking Metrics Newsletter, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer for advertising opportunities, questions, and more at roy@rmahd.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ Blog
○ RMAHD
○ Merch!

Pulse AI Analysis

Related Insights

More Like This

Author Joe Hill talks new novel "King Sorrow" and conquering the horror genre

41-year-old's clothing resale business brings in $6.5 million a year: 'You don't need a lot of money to start'

Trump hopes China will help push Russia towards Ukraine peace talks

Bitcoin price compression will spark expansion: Will BTC explode toward $120K?

Kim Kardashian reveals brain aneurysm diagnosis. Doctors share what to know.

How to use the new ChatGPT app integrations, including Spotify, Figma, Canva, and others